title: Amniotic fluid-borne hepatocyte growth factor protects rat pups against experimental necrotizing enterocolitis.
abstract: Fetal swallowing of amniotic fluid, which contains numerous cytokines and growth factors, plays a key role in gut mucosal development. Preterm birth interrupts this exposure to amniotic fluid-borne growth factors, possibly contributing to the increased risk of necrotizing enterocolitis (NEC) in premature infants. We hypothesized that supplementation of formula feeds with amniotic fluid can provide amniotic fluid-borne growth factors and prevent experimental NEC in rat pups. We compared NEC-like injury in rat pups fed with infant formula vs. formula supplemented either with 30% amniotic fluid or recombinant hepatocyte growth factor (HGF). Cytokines/growth factors in amniotic fluid were measured by immunoassays. Amniotic fluid and HGF effects on enterocyte migration, proliferation, and survival were measured in cultured IEC6 intestinal epithelial cells. Finally, we used an antibody array to investigate receptor tyrosine kinase (RTK) activation and immunoblots to measure phosphoinositide 3-kinase (PI3K) signaling. Amniotic fluid supplementation in oral feeds protected rat pups against NEC-like injury. HGF was the most abundant growth factor in rat amniotic fluid in our panel of analytes. Amniotic fluid increased cell migration, proliferation, and cell survival in vitro. These effects were reproduced by HGF and blocked by anti-HGF antibody or a PI3K inhibitor. HGF transactivated several RTKs in IEC6 cells, indicating that its effects extended to multiple signaling pathways. Finally, similar to amniotic fluid, recombinant HGF also reduced the frequency and severity of NEC-like injury in rat pups. Amniotic fluid supplementation protects rat pups against experimental NEC, which is mediated, at least in part, by HGF.
authors.affiliation: Department of Pediatrics (Division of Neonatology), University of Texas Medical Branch, Galveston, Texas;
authors.forename: Sunil K
authors.initials: SK
authors.lastname: Jain
authors.forename: Eric W
authors.initials: EW
authors.lastname: Baggerman
authors.forename: Krishnan
authors.initials: K
authors.lastname: Mohankumar
authors.forename: Kopperuncholan
authors.initials: K
authors.lastname: Namachivayam
authors.forename: Ramasamy
authors.initials: R
authors.lastname: Jagadeeswaran
authors.forename: Victor E
authors.initials: VE
authors.lastname: Reyes
authors.forename: Akhil
authors.initials: A
authors.lastname: Maheshwari
mesh_terms: D000653:Amniotic Fluid / Q000737:chemistry / Q000378:metabolism*; D000821:Animal Feed; D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D019587:Dietary Supplements; D020345:Enterocolitis, Necrotizing / Q000517:prevention & control*; D004847:Epithelial Cells / Q000187:drug effects; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D017228:Hepatocyte Growth Factor / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007223:Infant; D041943:Infant Formula; D007413:Intestinal Mucosa / Q000166:cytology; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics / Q000378:metabolism
chemical_list: D016207:Cytokines; D017228:Hepatocyte Growth Factor; D020794:Receptor Protein-Tyrosine Kinases
keywords: HGF; NEC; amniotic fluid; inflammation; phosphoinositide 3-kinase